Hoster E, Kluin-Nelemans H, Hermine O, et al. Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial. ASH 59th Annual Meeting & Exhibition, abstract 153.
Veelbelovende orale medicatie in ontwikkeling voor anemie bij CKD
jun 2021 | Benigne hematologie, Chronische nierschade